Supernus Pharmaceuticals Quarterly Balance Sheets Chart
Quarterly
|
Annual
Supernus Pharmaceuticals Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||
| current assets | |||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 144,711,000 | 115,848,000 | 69,331,000 | 31,673,000 | 52,089,000 | 63,401,000 | 75,054,000 | 94,985,000 | 24,706,000 | 58,442,000 | 93,120,000 | 111,492,000 | 173,428,000 | 115,715,000 | 203,434,000 | 215,281,000 | 223,771,000 | 255,642,000 | 288,640,000 | 204,293,000 | 210,975,000 | 225,767,000 | 181,381,000 | 116,889,000 | 87,344,000 | 122,778,000 | 123,818,000 | 35,205,000 | 444,140,000 | 81,924,000 | 61,737,000 | 59,599,000 | 54,305,000 | 36,156,000 | 19,830,000 | 26,294,000 | 33,110,000 | 25,810,000 | 37,780,000 | 11,956,000 | 12,252,000 | 22,945,000 | 33,907,000 | 18,909,000 | 23,412,000 | 47,242,000 | 15,866,000 |
| marketable securities | 377,885,000 | 347,742,000 | 384,281,000 | 371,537,000 | 295,098,000 | 234,335,000 | 179,820,000 | 105,204,000 | 126,950,000 | 170,126,000 | 368,214,000 | 280,297,000 | 187,359,000 | 196,485,000 | 136,246,000 | 228,571,000 | 186,070,000 | 135,459,000 | 133,893,000 | 147,657,000 | 163,839,000 | 175,104,000 | 165,692,000 | 179,808,000 | 171,222,000 | 170,165,000 | 156,407,000 | 139,208,000 | 45,585,000 | 32,626,000 | 31,229,000 | 27,533,000 | 26,024,000 | 24,058,000 | 25,427,000 | 31,408,000 | 36,681,000 | 39,026,000 | 34,783,000 | 35,314,000 | 46,615,000 | 64,293,000 | 68,725,000 | 50,983,000 | 37,256,000 | 29,150,000 | 21,513,000 |
| accounts receivable | 140,831,000 | 145,640,000 | 142,077,000 | 145,408,000 | 152,494,000 | 147,734,000 | 144,155,000 | 141,764,000 | 136,556,000 | 143,568,000 | 165,497,000 | 164,086,000 | 158,063,000 | 145,149,000 | 148,932,000 | 133,676,000 | 137,275,000 | 127,065,000 | 140,877,000 | 133,107,000 | 126,559,000 | 119,195,000 | 87,332,000 | 86,699,000 | 84,564,000 | 79,950,000 | 77,753,000 | 74,842,000 | 67,864,000 | 56,166,000 | 51,157,000 | 38,885,000 | 36,220,000 | 34,281,000 | 30,651,000 | 23,603,000 | 17,900,000 | 19,271,000 | 15,303,000 | 10,854,000 | 9,725,000 | 7,208,000 | 537,000 | 1,650,000 | 500,000 | ||
| inventories | 44,023,000 | 49,423,000 | 54,293,000 | 63,981,000 | 68,155,000 | 75,079,000 | 77,408,000 | 83,480,000 | 90,560,000 | 91,147,000 | 91,541,000 | 83,165,000 | 84,860,000 | 88,795,000 | 85,959,000 | 60,155,000 | 58,391,000 | 50,226,000 | 48,325,000 | 42,465,000 | 35,338,000 | 24,418,000 | 26,628,000 | 25,504,000 | 26,024,000 | 26,518,000 | 23,280,000 | 20,680,000 | 19,075,000 | 14,947,000 | 16,623,000 | 19,167,000 | 17,453,000 | 16,373,000 | 13,044,000 | 14,742,000 | 13,592,000 | 13,702,000 | 11,145,000 | 10,101,000 | 7,957,000 | 5,188,000 | 4,315,000 | 3,113,000 | |||
| prepaid expenses and other current assets | 31,416,000 | 28,931,000 | 36,088,000 | 27,404,000 | 23,166,000 | 23,772,000 | 16,676,000 | 23,927,000 | 44,766,000 | 16,299,000 | 15,779,000 | 24,846,000 | 21,410,000 | 22,372,000 | 27,019,000 | 30,692,000 | 33,737,000 | 17,631,000 | 18,682,000 | 24,493,000 | 20,442,000 | 12,564,000 | 11,611,000 | 18,182,000 | 21,757,000 | 20,556,000 | 9,299,000 | 14,581,000 | 6,582,000 | 5,667,000 | 4,746,000 | 4,573,000 | 4,201,000 | 3,272,000 | 5,003,000 | 6,504,000 | 4,457,000 | 3,696,000 | 3,298,000 | 3,058,000 | 2,559,000 | ||||||
| total current assets | 738,866,000 | 687,584,000 | 686,070,000 | 640,003,000 | 591,002,000 | 544,321,000 | 493,113,000 | 449,360,000 | 423,538,000 | 883,340,000 | 734,151,000 | 663,886,000 | 625,120,000 | 568,516,000 | 601,590,000 | 668,375,000 | 639,244,000 | 586,023,000 | 630,417,000 | 552,015,000 | 557,153,000 | 557,048,000 | 472,644,000 | 427,082,000 | 390,911,000 | 419,967,000 | 390,557,000 | 284,516,000 | 583,246,000 | 191,330,000 | 165,492,000 | 149,757,000 | 138,203,000 | 114,140,000 | 93,955,000 | 102,551,000 | 105,740,000 | 101,505,000 | 102,968,000 | 71,981,000 | 79,929,000 | 102,862,000 | 110,617,000 | 76,332,000 | 62,889,000 | 77,805,000 | 38,417,000 |
| property and equipment | 11,069,000 | 11,338,000 | 11,545,000 | 11,876,000 | 12,274,000 | 12,969,000 | 13,530,000 | 13,688,000 | 14,186,000 | 14,611,000 | 15,173,000 | 15,872,000 | 16,317,000 | 17,215,000 | 16,955,000 | 16,471,000 | 17,065,000 | 37,950,000 | 37,824,000 | 17,395,000 | 17,941,000 | 18,011,000 | 17,068,000 | 9,977,000 | 4,028,000 | 4,226,000 | 6,930,000 | 4,897,000 | 5,003,000 | 4,688,000 | 4,572,000 | 4,342,000 | 4,318,000 | 4,193,000 | 3,866,000 | 3,210,000 | 2,908,000 | 2,481,000 | 2,500,000 | 2,590,000 | 2,648,000 | 2,480,000 | 2,247,000 | 1,687,000 | 1,384,000 | 1,146,000 | 1,183,000 |
| intangible assets | 481,307,000 | 502,126,000 | 521,912,000 | 540,156,000 | 559,644,000 | 579,752,000 | 599,889,000 | 641,147,000 | 662,389,000 | 682,497,000 | 702,463,000 | 722,761,000 | 743,405,000 | 764,049,000 | 784,693,000 | 346,619,000 | 352,628,000 | 358,736,000 | 364,342,000 | 402,265,000 | 408,272,000 | 23,579,000 | 24,840,000 | 26,101,000 | 28,787,000 | 30,063,000 | 32,572,000 | 33,794,000 | 34,858,000 | 37,162,000 | 28,989,000 | 29,450,000 | 15,526,000 | 15,785,000 | 16,108,000 | 16,627,000 | 11,597,000 | 7,839,000 | 4,135,000 | 3,083,000 | 2,157,000 | 817,000 | |||||
| goodwill | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,383,000 | 115,414,000 | 115,414,000 | 117,516,000 | 77,963,000 | 77,963,000 | 77,911,000 | 77,911,000 | 89,143,000 | 88,095,000 | ||||||||||||||||||||||||||
| deferred income tax assets | 6,181,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 27,963,000 | 29,223,000 | 31,527,000 | 33,647,000 | 35,890,000 | 38,367,000 | 37,505,000 | 38,821,000 | 38,489,000 | 40,184,000 | 39,806,000 | 41,290,000 | 47,344,000 | 48,986,000 | 49,232,000 | 40,133,000 | 40,687,000 | 30,257,000 | 43,249,000 | 18,324,000 | 17,118,000 | 538,000 | 615,000 | 574,000 | 581,000 | 625,000 | 360,000 | 360,000 | 363,000 | 55,000 | 55,000 | 61,000 | |||||||||||||||
| total assets | 1,382,405,000 | 1,347,290,000 | 1,368,073,000 | 1,342,701,000 | 1,315,829,000 | 1,304,090,000 | 1,277,673,000 | 1,285,160,000 | 1,293,099,000 | 1,791,808,000 | 1,702,508,000 | 1,693,129,000 | 1,694,973,000 | 1,639,517,000 | 1,689,152,000 | 1,555,040,000 | 1,573,060,000 | 1,507,443,000 | 1,504,102,000 | 1,510,022,000 | 1,491,020,000 | 1,189,866,000 | 1,160,282,000 | 1,106,909,000 | 1,063,675,000 | 1,025,448,000 | 922,512,000 | 852,799,000 | 825,160,000 | 385,478,000 | 346,370,000 | 322,256,000 | 285,116,000 | 218,633,000 | 194,474,000 | 166,770,000 | 154,168,000 | 139,637,000 | 126,325,000 | 94,190,000 | 97,520,000 | 123,765,000 | 131,973,000 | 79,061,000 | 67,014,000 | 79,965,000 | 43,202,000 |
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued liabilities | 77,739,000 | 76,891,000 | 76,352,000 | 75,803,000 | 82,611,000 | 86,402,000 | 79,569,000 | 78,471,000 | 83,044,000 | 95,345,000 | 96,342,000 | 110,302,000 | 133,000,000 | 89,432,000 | 117,683,000 | 72,286,000 | 79,993,000 | 70,099,000 | 78,934,000 | ||||||||||||||||||||||||||||
| accrued product returns and rebates | 180,916,000 | 170,133,000 | 168,705,000 | 169,124,000 | 175,119,000 | 167,226,000 | 154,274,000 | 162,473,000 | 148,826,000 | 147,852,000 | 151,665,000 | 158,470,000 | 145,761,000 | 140,181,000 | 132,724,000 | 132,048,000 | 173,598,000 | 128,736,000 | 126,192,000 | 136,973,000 | 144,105,000 | 119,453,000 | 107,629,000 | 98,050,000 | 95,934,000 | 88,200,000 | |||||||||||||||||||||
| contingent consideration, current portion | 30,000,000 | 47,340,000 | 46,581,000 | 47,303,000 | 51,379,000 | 52,070,000 | 45,880,000 | 20,720,000 | 21,120,000 | 47,590,000 | 47,240,000 | 46,890,000 | 44,840,000 | 23,570,000 | 23,540,000 | 31,520,000 | 30,900,000 | 82,900,000 | 23,500,000 | ||||||||||||||||||||||||||||
| other current liabilities | 27,705,000 | 4,748,000 | 3,623,000 | 9,547,000 | 4,283,000 | 710,000 | 7,485,000 | 16,863,000 | 8,187,000 | 8,626,000 | 8,055,000 | 20,132,000 | 6,807,000 | 6,316,000 | 10,457,000 | 9,082,000 | |||||||||||||||||||||||||||||||
| total current liabilities | 286,360,000 | 281,772,000 | 292,397,000 | 291,508,000 | 308,656,000 | 314,554,000 | 290,196,000 | 287,534,000 | 252,590,000 | 731,545,000 | 687,958,000 | 725,987,000 | 735,536,000 | 284,558,000 | 315,379,000 | 234,711,000 | 283,447,000 | 240,812,000 | 245,108,000 | 299,606,000 | 269,276,000 | 168,335,000 | 160,587,000 | 149,717,000 | 143,971,000 | 151,706,000 | 138,346,000 | 103,934,000 | 119,088,000 | 104,956,000 | 85,524,000 | 82,003,000 | 71,647,000 | 65,572,000 | 54,124,000 | 43,128,000 | 36,414,000 | 26,855,000 | 22,126,000 | 19,187,000 | 27,102,000 | 25,071,000 | 16,024,000 | 27,008,000 | 24,590,000 | 21,881,000 | 19,912,000 |
| operating lease liabilities, long-term | 24,383,000 | 26,368,000 | 27,382,000 | 28,926,000 | 30,294,000 | 32,994,000 | 33,841,000 | 34,177,000 | 36,511,000 | 36,028,000 | 37,080,000 | 39,891,000 | |||||||||||||||||||||||||||||||||||
| deferred income tax liabilities | 981,000 | 4,961,000 | 7,364,000 | 11,440,000 | 19,501,000 | 24,963,000 | 35,224,000 | 44,300,000 | 49,668,000 | 49,809,000 | 58,164,000 | 59,313,000 | 62,843,000 | 85,355,000 | 34,146,000 | 32,986,000 | 31,742,000 | 35,215,000 | 37,941,000 | 35,716,000 | |||||||||||||||||||||||||||
| other liabilities | 7,762,000 | 7,464,000 | 7,600,000 | 7,350,000 | 7,288,000 | 6,899,000 | 6,422,000 | 8,596,000 | 8,734,000 | 8,614,000 | 8,692,000 | 10,371,000 | 11,965,000 | 14,145,000 | 16,380,000 | 18,186,000 | 19,092,000 | 39,675,000 | 42,791,000 | 9,304,000 | 9,560,000 | 9,743,000 | 9,409,000 | 11,211,000 | 10,955,000 | ||||||||||||||||||||||
| total liabilities | 318,505,000 | 316,585,000 | 332,340,000 | 335,551,000 | 358,375,000 | 374,924,000 | 356,157,000 | 372,969,000 | 373,191,000 | 879,658,000 | 816,304,000 | 840,331,000 | 853,539,000 | 811,071,000 | 873,301,000 | 744,572,000 | 787,481,000 | 752,999,000 | 759,244,000 | 801,143,000 | 825,046,000 | 576,483,000 | 564,854,000 | 549,652,000 | 540,771,000 | 545,430,000 | 500,576,000 | 462,307,000 | 473,291,000 | 133,815,000 | 116,973,000 | 116,192,000 | 111,745,000 | 77,611,000 | 66,335,000 | 57,334,000 | 51,803,000 | 45,053,000 | 60,206,000 | 60,821,000 | 68,507,000 | 111,312,000 | 96,081,000 | 37,789,000 | 42,383,000 | 41,985,000 | 42,928,000 |
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 56,000 | 56,000 | 56,000 | 55,000 | 55,000 | 55,000 | 55,000 | 55,000 | 55,000 | 54,000 | 54,000 | 54,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 52,000 | 52,000 | 52,000 | 52,000 | 52,000 | 52,000 | 51,000 | 51,000 | 50,000 | 50,000 | 50,000 | 49,000 | 49,000 | 48,000 | 48,000 | 43,000 | 42,000 | 42,000 | 31,000 | 24,000 | 24,000 | 2,000 | ||
| additional paid-in capital | 496,946,000 | 486,209,000 | 479,440,000 | 465,919,000 | 455,170,000 | 446,960,000 | 439,493,000 | 431,956,000 | 424,266,000 | 416,232,000 | 408,115,000 | 401,026,000 | 389,586,000 | 383,016,000 | 434,337,000 | 428,726,000 | 424,175,000 | 415,950,000 | 409,332,000 | 403,396,000 | 398,829,000 | 392,430,000 | 388,410,000 | 383,525,000 | 379,369,000 | 373,707,000 | 365,396,000 | 361,971,000 | 352,257,000 | 291,841,000 | 285,572,000 | 279,792,000 | 271,801,000 | 270,059,000 | 267,576,000 | 261,006,000 | 258,202,000 | 252,341,000 | 229,123,000 | 224,196,000 | 223,041,000 | 168,625,000 | 168,122,000 | 145,999,000 | 97,378,000 | 97,209,000 | 49,462,000 |
| accumulated other comprehensive loss, net of tax | -200,000 | -159,000 | -189,000 | -372,000 | -534,000 | -1,206,000 | -1,775,000 | -2,329,000 | |||||||||||||||||||||||||||||||||||||||
| retained earnings | 567,098,000 | 544,599,000 | 556,426,000 | 541,098,000 | 502,601,000 | 482,685,000 | 482,561,000 | 481,386,000 | 497,362,000 | 498,193,000 | 481,245,000 | 455,764,000 | 454,015,000 | 446,150,000 | 379,922,000 | 377,480,000 | 355,918,000 | 332,192,000 | 326,498,000 | 295,730,000 | 255,733,000 | 221,066,000 | 199,548,000 | 166,419,000 | 137,559,000 | 104,832,000 | 60,599,000 | 32,588,000 | 1,851,000 | ||||||||||||||||||
| total stockholders' equity | 1,063,900,000 | 12,453,000 | 35,892,000 | ||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders' equity | 1,382,405,000 | 123,765,000 | 131,973,000 | ||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 1,030,705,000 | 1,035,733,000 | 1,007,150,000 | 957,454,000 | 929,166,000 | 921,516,000 | 912,191,000 | 919,908,000 | 912,150,000 | 886,204,000 | 852,798,000 | 841,434,000 | 828,446,000 | 815,851,000 | 810,468,000 | 785,579,000 | 754,444,000 | 744,858,000 | 708,879,000 | 665,974,000 | 613,383,000 | 595,428,000 | 557,257,000 | 522,904,000 | 480,018,000 | 421,936,000 | 390,492,000 | 351,869,000 | 251,663,000 | 229,397,000 | 206,064,000 | 173,371,000 | 141,022,000 | 128,139,000 | 109,436,000 | 102,365,000 | 94,584,000 | 66,119,000 | 33,369,000 | 29,013,000 | 41,272,000 | 24,631,000 | 37,980,000 | 274,000 | |||
| total liabilities and stockholders’ equity | 1,347,290,000 | 1,368,073,000 | 1,342,701,000 | 1,315,829,000 | 1,304,090,000 | 1,277,673,000 | 1,285,160,000 | 1,293,099,000 | 1,791,808,000 | 1,702,508,000 | 1,693,129,000 | 1,694,973,000 | 1,639,517,000 | 1,689,152,000 | 1,555,040,000 | 1,573,060,000 | 1,507,443,000 | 1,504,102,000 | 1,510,022,000 | 1,491,020,000 | 1,189,866,000 | 1,160,282,000 | 1,106,909,000 | 1,063,675,000 | 1,025,448,000 | 922,512,000 | 852,799,000 | 825,160,000 | 385,478,000 | 346,370,000 | 322,256,000 | 285,116,000 | 218,633,000 | 194,474,000 | 166,770,000 | 154,168,000 | 139,637,000 | 126,325,000 | 94,190,000 | 97,520,000 | 79,061,000 | 67,014,000 | 79,965,000 | 43,202,000 | |||
| long-term marketable securities | 11,662,000 | 25,125,000 | 37,478,000 | 54,157,000 | 131,937,000 | 147,373,000 | 125,337,000 | ||||||||||||||||||||||||||||||||||||||||
| contingent consideration, long-term | 403,000 | 697,000 | 976,000 | 7,774,000 | 33,390,000 | 53,320,000 | 9,781,000 | 9,645,000 | 9,252,000 | ||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive earnings, net of tax | 78,000 | -593,000 | -3,210,000 | -4,046,000 | -2,220,000 | -773,000 | 1,539,000 | 4,209,000 | 5,433,000 | 6,249,000 | 8,975,000 | 9,700,000 | 11,359,000 | -166,000 | 7,417,000 | 7,261,000 | 5,924,000 | 1,427,000 | |||||||||||||||||||||||||||||
| long term marketable securities | 16,617,000 | 93,896,000 | 119,166,000 | 405,479,000 | 445,473,000 | 416,566,000 | 350,359,000 | 388,185,000 | 358,673,000 | 534,712,000 | 591,773,000 | 596,442,000 | 593,754,000 | 522,551,000 | 460,304,000 | 503,312,000 | 175,064,000 | 123,123,000 | 104,632,000 | 89,163,000 | 67,044,000 | 67,809,000 | 68,790,000 | 43,967,000 | 33,488,000 | 27,315,000 | 15,763,000 | 15,462,000 | 11,662,000 | ||||||||||||||||||
| convertible notes | 402,500,000 | 401,968,000 | 401,438,000 | 400,909,000 | 400,382,000 | 379,252,000 | 374,788,000 | 370,383,000 | 366,038,000 | 361,751,000 | 357,521,000 | 353,349,000 | 349,232,000 | 345,170,000 | 341,163,000 | 337,210,000 | 333,310,000 | 325,666,000 | 321,920,000 | 318,225,000 | 1,472,000 | 3,310,000 | 5,772,000 | 5,699,000 | 5,627,000 | ||||||||||||||||||||||
| contingent consideration, long term | 1,380,000 | 33,847,000 | 35,637,000 | 45,480,000 | 45,430,000 | 46,200,000 | 45,800,000 | 33,000,000 | 92,200,000 | ||||||||||||||||||||||||||||||||||||||
| operating lease liabilities, long term | 33,196,000 | 35,998,000 | 41,298,000 | 37,261,000 | 36,143,000 | 28,532,000 | 28,579,000 | 29,522,000 | 30,108,000 | ||||||||||||||||||||||||||||||||||||||
| restricted cash | 403,758,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| line of credit | 78,363,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| deferred income taxes | 34,067,000 | 32,063,000 | 27,953,000 | 25,975,000 | 27,967,000 | 31,367,000 | 25,528,000 | 26,254,000 | 28,807,000 | 30,449,000 | 37,863,000 | ||||||||||||||||||||||||||||||||||||
| operating lease assets | 21,019,000 | 21,289,000 | |||||||||||||||||||||||||||||||||||||||||||||
| finance lease asset | 21,676,000 | 22,479,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 11,193,000 | 5,515,000 | 3,124,000 | 10,141,000 | 3,090,000 | 4,081,000 | 7,240,000 | 9,838,000 | 2,943,000 | 3,333,000 | 6,262,000 | 7,577,000 | 5,056,000 | 2,685,000 | 2,243,000 | 2,646,000 | 2,812,000 | 4,518,000 | 859,000 | ||||||||||||||||||||||||||||
| accrued expenses and other current liabilities | 56,289,000 | 58,818,000 | 33,003,000 | 37,130,000 | 40,800,000 | 38,614,000 | 36,607,000 | ||||||||||||||||||||||||||||||||||||||||
| income taxes payable | 25,052,000 | 9,097,000 | 2,443,000 | 4,818,000 | 2,674,000 | 17,233,000 | 8,548,000 | 16,265,000 | 6,489,000 | ||||||||||||||||||||||||||||||||||||||
| operating lease liabilities, current portion | 3,741,000 | 3,560,000 | |||||||||||||||||||||||||||||||||||||||||||||
| finance lease liability, current portion | 3,612,000 | 4,201,000 | |||||||||||||||||||||||||||||||||||||||||||||
| nonrecourse liability related to sale of future royalties, current portion | 4,898,000 | 4,525,000 | 3,658,000 | 2,959,000 | |||||||||||||||||||||||||||||||||||||||||||
| nonrecourse liability related to sale of future royalties, long term | 14,960,000 | 16,455,000 | 18,369,000 | 20,305,000 | |||||||||||||||||||||||||||||||||||||||||||
| finance lease liability, long term | 19,289,000 | 18,382,000 | |||||||||||||||||||||||||||||||||||||||||||||
| lease assets | 21,911,000 | 21,279,000 | 18,780,000 | 19,639,000 | 20,049,000 | ||||||||||||||||||||||||||||||||||||||||||
| lease liabilities, long term | 30,804,000 | 30,440,000 | 27,256,000 | 27,535,000 | 27,824,000 | ||||||||||||||||||||||||||||||||||||||||||
| nonrecourse liability related to sale of future royalties; current portion | 3,244,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| nonrecourse liability related to sale of future royalties; long term | 19,248,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| non-recourse liability related to sale of future royalties, current portion | 2,668,000 | 2,426,000 | 1,892,000 | 1,659,000 | 1,432,000 | 5,254,000 | 4,997,000 | 4,645,000 | |||||||||||||||||||||||||||||||||||||||
| non-recourse liability related to sale of future royalties, long term | 21,100,000 | 21,957,000 | 23,305,000 | 23,867,000 | 24,370,000 | 22,702,000 | 24,184,000 | 25,555,000 | |||||||||||||||||||||||||||||||||||||||
| other non-current liabilities | 10,633,000 | 13,259,000 | 12,586,000 | 11,608,000 | 4,936,000 | 4,500,000 | 3,936,000 | 4,199,000 | 4,322,000 | 4,391,000 | 3,815,000 | 3,355,000 | 2,561,000 | 3,015,000 | 2,784,000 | 2,101,000 | 2,401,000 | 2,158,000 | 1,860,000 | 1,558,000 | 1,432,000 | 1,382,000 | |||||||||||||||||||||||||
| other non-current assets | 782,000 | 752,000 | 735,000 | 368,000 | 349,000 | 350,000 | 332,000 | 320,000 | 311,000 | 415,000 | 435,000 | 497,000 | 360,000 | 361,000 | 360,000 | ||||||||||||||||||||||||||||||||
| accrued sales deductions | 85,970,000 | 70,044,000 | 73,034,000 | 59,772,000 | 47,621,000 | 43,450,000 | 39,694,000 | 35,019,000 | 28,697,000 | 18,820,000 | |||||||||||||||||||||||||||||||||||||
| accrued expenses | 32,098,000 | 29,288,000 | 25,024,000 | 26,892,000 | 23,434,000 | 26,890,000 | 26,719,000 | 28,102,000 | 22,573,000 | 21,353,000 | 31,753,000 | 25,853,000 | |||||||||||||||||||||||||||||||||||
| deferred licensing revenue | 287,000 | 287,000 | 287,000 | 207,000 | 208,000 | 208,000 | 143,000 | 143,000 | 143,000 | 143,000 | 143,000 | 173,000 | 234,000 | 325,000 | 417,000 | ||||||||||||||||||||||||||||||||
| deferred licensing revenue, net of current portion | 1,221,000 | 1,293,000 | 1,365,000 | 1,554,000 | 1,606,000 | 1,658,000 | 1,167,000 | 1,202,000 | 1,238,000 | 1,310,000 | 1,345,000 | 1,381,000 | 1,452,000 | 738,000 | 774,000 | ||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||
| derivative liabilities | 23,000 | 287,000 | 412,000 | 535,000 | 1,156,000 | 2,070,000 | 2,691,000 | 7,258,000 | 8,834,000 | 9,565,000 | 22,213,000 | 18,061,000 | |||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income, net of tax | 252,000 | 216,000 | 32,000 | ||||||||||||||||||||||||||||||||||||||||||||
| accumulated deficit | -156,122,000 | -132,026,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred legal fees | 11,887,000 | 11,331,000 | 17,437,000 | 16,386,000 | 11,444,000 | ||||||||||||||||||||||||||||||||||||||||||
| accrued income taxes payable | 1,608,000 | 1,675,000 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred tax asset | 42,256,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| non-recourse liability related to sale of future royalties-current portion | 2,342,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| non-recourse liability related to sale of future royalties-long term | 28,286,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income, net of tax benefit | 127,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 549,000 | 168,000 | 1,000 | 1,000 | -235,000 | 6,000 | 8,000 | ||||||||||||||||||||||||||||||||||||||||
| convertible notes, net of discount | 8,068,000 | 8,762,000 | 11,708,000 | 26,497,000 | 28,671,000 | 28,358,000 | 60,175,000 | 59,100,000 | |||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -81,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| interest receivable | 493,000 | 496,000 | 636,000 | 982,000 | 791,000 | 672,000 | |||||||||||||||||||||||||||||||||||||||||
| deferred financing costs, current | 166,000 | 202,000 | 185,000 | 431,000 | 430,000 | 144,000 | 144,000 | 144,000 | 144,000 | ||||||||||||||||||||||||||||||||||||||
| deferred financing costs, long-term | 599,000 | 713,000 | 764,000 | 2,031,000 | 2,109,000 | 53,000 | 142,000 | 161,000 | 2,686,000 | ||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 21,983,000 | 19,044,000 | 14,658,000 | 14,472,000 | 11,732,000 | 10,903,000 | 10,485,000 | 9,175,000 | 9,337,000 | ||||||||||||||||||||||||||||||||||||||
| deferred product revenue | 12,271,000 | 10,365,000 | 3,967,000 | 3,551,000 | |||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses and other | 1,815,000 | 1,912,000 | 861,000 | 1,276,000 | 1,010,000 | 618,000 | |||||||||||||||||||||||||||||||||||||||||
| long term investments | 15,215,000 | 16,072,000 | 1,804,000 | ||||||||||||||||||||||||||||||||||||||||||||
| secured notes payable, net of discount | 12,137,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| secured notes payable, net of current portion and discount | 7,975,000 | 14,116,000 | |||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||
| 2013 and december 31, 2012; 30,945,205 and 30,621,869 shares issued and | |||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at september 30, 2013 and december 31, 2012, respectively | 31,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| purchased patents | 568,000 | 626,000 | 740,000 | 798,000 | 855,000 | ||||||||||||||||||||||||||||||||||||||||||
| 2013 and december 31, 2012; 30,940,330 and 30,621,869 shares issued and | |||||||||||||||||||||||||||||||||||||||||||||||
| outstanding at june 30, 2013 and december 31, 2012, respectively | 31,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| warrant liability | 172,000 | 1,463,000 | 1,169,000 | 1,025,000 | |||||||||||||||||||||||||||||||||||||||||||
| series a preferred stock, 0.001par value - 65,000,000 shares authorized at march 31, 2013 and december 31, 2012; zero shares issued and outstanding at march 31, 2013 and december 31, 2012 | |||||||||||||||||||||||||||||||||||||||||||||||
| marketable securities - restricted | 275,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| inventory | 26,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| accrued compensation | 1,801,000 | 1,335,000 | 901,000 | ||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 576,000 | 365,000 | 232,000 | ||||||||||||||||||||||||||||||||||||||||||||
| interest payable | 238,000 | 259,000 | 271,000 | ||||||||||||||||||||||||||||||||||||||||||||
| secured notes payable | 11,490,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue, net of current portion | 381,000 | 183,000 | 407,000 | ||||||||||||||||||||||||||||||||||||||||||||
| supplemental executive retirement plan | 275,000 | 259,000 | 276,000 | ||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value - 49,625,000 shares and 65,000,000 shares authorized at december 31, 2011 and september 30, 2012, respectively; 49,000,000 shares issued and outstanding at december 31, 2011 and zero shares issued and outstanding as of september 30, 2012, respectively; aggregate liquidation preference of 69,520 and zero at december 31, 2011 and september 30, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||
| marketable securities—restricted | 259,000 | 276,000 | |||||||||||||||||||||||||||||||||||||||||||||
| secured notes payable, current | 10,747,000 | 9,171,000 | |||||||||||||||||||||||||||||||||||||||||||||
| secured notes payable, net of current portion | 17,061,000 | 19,926,000 | |||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value—49,625,000 shares and 65,000,000 shares authorized at december 31, 2011 and june 30, 2012 respectively; 49,000,000 shares issued and outstanding at december 31, 2011 and 0 shares issued and outstanding at june 30, 2012; aggregate liquidation preference of 69,520 and zero at december 31, 2011 and june 30, 2012, respectively | |||||||||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value—49,625,000 shares authorized at december 31, 2011 and march 31, 2012; 49,000,000 shares issued and outstanding at december 31, 2011 and march 31, 2012; aggregate liquidation preference of 69,520 and 70,378 at december 31, 2011 and march 31, 2012, respectively | 49,000 |
We provide you with 20 years of balance sheets for Supernus Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Supernus Pharmaceuticals. Explore the full financial landscape of Supernus Pharmaceuticals stock with our expertly curated balance sheets.
The information provided in this report about Supernus Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.